vs

Side-by-side financial comparison of LivaNova PLC (LIVN) and ONE Group Hospitality, Inc. (STKS). Click either name above to swap in a different company.

LivaNova PLC is the larger business by last-quarter revenue ($360.9M vs $207.0M, roughly 1.7× ONE Group Hospitality, Inc.). LivaNova PLC runs the higher net margin — 8.6% vs -3.1%, a 11.6% gap on every dollar of revenue. On growth, LivaNova PLC posted the faster year-over-year revenue change (12.1% vs -6.7%). LivaNova PLC produced more free cash flow last quarter ($50.2M vs $-329.0K). Over the past eight quarters, ONE Group Hospitality, Inc.'s revenue compounded faster (56.1% CAGR vs 10.6%).

LivaNova, plc is an American medical device manufacturer based in the UK. The company develops devices used for cardiac surgery and neuromodulation. The company was formed in 2015 by a $2.7B merger between Houston, Texas-based Cyberonics, Inc. and Milan, Italy-based Sorin S.p.a. The company trades on the NASDAQ stock exchange under the ticker symbol "LIVN".

Target Hospitality is a company that provides workforce lodging and other temporary, modular housing used for oil, gas and mining operations; large-scale events; and disaster relief. Target Hospitality is based in The Woodlands, Texas, and also has offices in Williston, North Dakota; Denver, Colorado; Calgary, Alberta.

LIVN vs STKS — Head-to-Head

Bigger by revenue
LIVN
LIVN
1.7× larger
LIVN
$360.9M
$207.0M
STKS
Growing faster (revenue YoY)
LIVN
LIVN
+18.8% gap
LIVN
12.1%
-6.7%
STKS
Higher net margin
LIVN
LIVN
11.6% more per $
LIVN
8.6%
-3.1%
STKS
More free cash flow
LIVN
LIVN
$50.5M more FCF
LIVN
$50.2M
$-329.0K
STKS
Faster 2-yr revenue CAGR
STKS
STKS
Annualised
STKS
56.1%
10.6%
LIVN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LIVN
LIVN
STKS
STKS
Revenue
$360.9M
$207.0M
Net Profit
$30.9M
$-6.4M
Gross Margin
65.2%
Operating Margin
11.8%
2.2%
Net Margin
8.6%
-3.1%
Revenue YoY
12.1%
-6.7%
Net Profit YoY
-44.7%
-531.8%
EPS (diluted)
$0.57
$-0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LIVN
LIVN
STKS
STKS
Q4 25
$360.9M
$207.0M
Q3 25
$357.8M
$180.2M
Q2 25
$352.5M
$207.4M
Q1 25
$316.9M
$211.1M
Q4 24
$321.8M
$221.9M
Q3 24
$318.1M
$194.0M
Q2 24
$318.6M
$172.5M
Q1 24
$294.9M
$85.0M
Net Profit
LIVN
LIVN
STKS
STKS
Q4 25
$30.9M
$-6.4M
Q3 25
$26.8M
$-76.7M
Q2 25
$27.2M
$-10.1M
Q1 25
$-327.3M
$975.0K
Q4 24
$55.9M
$1.5M
Q3 24
$33.0M
$-9.3M
Q2 24
$16.3M
$-7.3M
Q1 24
$-41.9M
$-2.1M
Gross Margin
LIVN
LIVN
STKS
STKS
Q4 25
65.2%
Q3 25
68.4%
Q2 25
67.8%
Q1 25
69.7%
Q4 24
68.2%
Q3 24
70.8%
Q2 24
68.7%
Q1 24
70.3%
Operating Margin
LIVN
LIVN
STKS
STKS
Q4 25
11.8%
2.2%
Q3 25
15.1%
-4.4%
Q2 25
15.4%
0.3%
Q1 25
15.3%
5.1%
Q4 24
11.5%
5.5%
Q3 24
11.2%
-1.9%
Q2 24
12.6%
0.6%
Q1 24
5.5%
-0.7%
Net Margin
LIVN
LIVN
STKS
STKS
Q4 25
8.6%
-3.1%
Q3 25
7.5%
-42.6%
Q2 25
7.7%
-4.9%
Q1 25
-103.3%
0.5%
Q4 24
17.4%
0.7%
Q3 24
10.4%
-4.8%
Q2 24
5.1%
-4.3%
Q1 24
-14.2%
-2.4%
EPS (diluted)
LIVN
LIVN
STKS
STKS
Q4 25
$0.57
$-0.50
Q3 25
$0.49
$-2.75
Q2 25
$0.50
$-0.59
Q1 25
$-6.01
$-0.21
Q4 24
$1.04
$-0.18
Q3 24
$0.60
$-0.53
Q2 24
$0.30
$-0.38
Q1 24
$-0.78
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LIVN
LIVN
STKS
STKS
Cash + ST InvestmentsLiquidity on hand
$635.6M
$4.2M
Total DebtLower is stronger
$376.1M
$354.2M
Stockholders' EquityBook value
$1.2B
$-75.8M
Total Assets
$2.6B
$884.2M
Debt / EquityLower = less leverage
0.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LIVN
LIVN
STKS
STKS
Q4 25
$635.6M
$4.2M
Q3 25
$646.1M
$5.5M
Q2 25
$593.6M
$4.7M
Q1 25
$738.4M
$21.4M
Q4 24
$428.9M
$27.6M
Q3 24
$346.4M
$28.2M
Q2 24
$329.2M
$32.2M
Q1 24
$309.2M
$15.4M
Total Debt
LIVN
LIVN
STKS
STKS
Q4 25
$376.1M
$354.2M
Q3 25
$434.5M
$355.0M
Q2 25
$430.6M
$347.4M
Q1 25
$628.2M
$348.3M
Q4 24
$627.0M
$348.3M
Q3 24
$625.5M
$349.1M
Q2 24
$624.5M
$350.0M
Q1 24
$623.8M
$73.5M
Stockholders' Equity
LIVN
LIVN
STKS
STKS
Q4 25
$1.2B
$-75.8M
Q3 25
$1.2B
$-61.5M
Q2 25
$1.1B
$23.0M
Q1 25
$1.0B
$40.5M
Q4 24
$1.3B
$45.9M
Q3 24
$1.3B
$51.4M
Q2 24
$1.2B
$68.1M
Q1 24
$1.2B
$68.3M
Total Assets
LIVN
LIVN
STKS
STKS
Q4 25
$2.6B
$884.2M
Q3 25
$2.6B
$879.5M
Q2 25
$2.5B
$935.7M
Q1 25
$2.6B
$956.0M
Q4 24
$2.5B
$960.1M
Q3 24
$2.5B
$953.5M
Q2 24
$2.5B
$945.9M
Q1 24
$2.5B
$309.3M
Debt / Equity
LIVN
LIVN
STKS
STKS
Q4 25
0.31×
Q3 25
0.38×
Q2 25
0.38×
15.07×
Q1 25
0.61×
8.61×
Q4 24
0.47×
7.59×
Q3 24
0.48×
6.79×
Q2 24
0.50×
5.14×
Q1 24
0.51×
1.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LIVN
LIVN
STKS
STKS
Operating Cash FlowLast quarter
$82.4M
$13.1M
Free Cash FlowOCF − Capex
$50.2M
$-329.0K
FCF MarginFCF / Revenue
13.9%
-0.2%
Capex IntensityCapex / Revenue
8.9%
6.5%
Cash ConversionOCF / Net Profit
2.67×
TTM Free Cash FlowTrailing 4 quarters
$173.3M
$-27.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LIVN
LIVN
STKS
STKS
Q4 25
$82.4M
$13.1M
Q3 25
$85.1M
$5.9M
Q2 25
$62.9M
$2.8M
Q1 25
$24.0M
$8.5M
Q4 24
$78.7M
$18.5M
Q3 24
$51.0M
$19.1M
Q2 24
$43.4M
$-3.8M
Q1 24
$10.0M
$10.4M
Free Cash Flow
LIVN
LIVN
STKS
STKS
Q4 25
$50.2M
$-329.0K
Q3 25
$62.2M
$-6.1M
Q2 25
$47.8M
$-15.0M
Q1 25
$13.2M
$-5.8M
Q4 24
$68.3M
$733.0K
Q3 24
$32.8M
$287.0K
Q2 24
$31.2M
$-23.0M
Q1 24
$3.6M
$-5.4M
FCF Margin
LIVN
LIVN
STKS
STKS
Q4 25
13.9%
-0.2%
Q3 25
17.4%
-3.4%
Q2 25
13.6%
-7.2%
Q1 25
4.2%
-2.7%
Q4 24
21.2%
0.3%
Q3 24
10.3%
0.1%
Q2 24
9.8%
-13.3%
Q1 24
1.2%
-6.4%
Capex Intensity
LIVN
LIVN
STKS
STKS
Q4 25
8.9%
6.5%
Q3 25
6.4%
6.7%
Q2 25
4.3%
8.6%
Q1 25
3.4%
6.8%
Q4 24
3.2%
8.0%
Q3 24
5.7%
9.7%
Q2 24
3.8%
11.1%
Q1 24
2.2%
18.6%
Cash Conversion
LIVN
LIVN
STKS
STKS
Q4 25
2.67×
Q3 25
3.18×
Q2 25
2.32×
Q1 25
8.76×
Q4 24
1.41×
12.54×
Q3 24
1.55×
Q2 24
2.65×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LIVN
LIVN

Other$169.4M47%
Neuromodulation Segment$119.7M33%
Cardiopulmonary Segment$71.8M20%

STKS
STKS

Benihanas$111.3M54%
Steakhouse Restaurant$59.2M29%
Grill Concepts$32.3M16%
Other$4.2M2%

Related Comparisons